Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease.

Vacirca D, Delunardo F, Matarrese P, Colasanti T, Margutti P, Siracusano A, Pontecorvo S, Capozzi A, Sorice M, Francia A, Malorni W, Ortona E.

Neurobiol Aging. 2012 Apr;33(4):753-66. doi: 10.1016/j.neurobiolaging.2010.05.013. Epub 2010 Jul 1.

PMID:
20594618
2.

Anti-ATP synthase autoantibodies from patients with Alzheimer's disease reduce extracellular HDL level.

Vacirca D, Barbati C, Scazzocchio B, Masella R, Rosano G, Malorni W, Ortona E.

J Alzheimers Dis. 2011;26(3):441-5. doi: 10.3233/JAD-2011-110350.

PMID:
21677380
3.

Autoantibodies to endothelial cell surface ATP synthase, the endogenous receptor for hsp60, might play a pathogenic role in vasculatides.

Alard JE, Hillion S, Guillevin L, Saraux A, Pers JO, Youinou P, Jamin C.

PLoS One. 2011 Feb 7;6(2):e14654. doi: 10.1371/journal.pone.0014654.

4.

Anti-ATP synthase autoantibodies induce neuronal death by apoptosis and impair cognitive performance in C57BL/6J mice.

Berry A, Vacirca D, Capoccia S, Bellisario V, Malorni W, Ortona E, Cirulli F.

J Alzheimers Dis. 2013;33(2):317-21. doi: 10.3233/JAD-2012-121312.

PMID:
22954670
5.

High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.

Hasan SI, Mohd Ashari NS, Mohd Daud K, Che Husin CM.

Int J Rheum Dis. 2013 Aug;16(4):430-6. doi: 10.1111/1756-185X.12062. Epub 2013 Apr 27.

PMID:
23992264
7.

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma.

Creaney J, Dick IM, Yeoman D, Wong S, Robinson BW.

PLoS One. 2011;6(10):e26515. doi: 10.1371/journal.pone.0026515. Epub 2011 Oct 17.

8.

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.

Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G.

Neurobiol Aging. 2002 May-Jun;23(3):371-6.

PMID:
11959398
9.

Proteomic analysis of extracellular ATP-regulated proteins identifies ATP synthase beta-subunit as a novel plant cell death regulator.

Chivasa S, Tomé DF, Hamilton JM, Slabas AR.

Mol Cell Proteomics. 2011 Mar;10(3):M110.003905. doi: 10.1074/mcp.M110.003905. Epub 2010 Dec 14.

10.

A cell model for the initial phase of sporadic Alzheimer's disease.

Stockburger C, Gold VA, Pallas T, Kolesova N, Miano D, Leuner K, Müller WE.

J Alzheimers Dis. 2014;42(2):395-411. doi: 10.3233/JAD-140381.

PMID:
24898661
11.

Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches.

Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Oyama M, Kozuka-Hata H, Hattori H, Nagata K, Yamanaka H, Hara M.

Mol Cell Proteomics. 2011 Jun;10(6):M110.005330. doi: 10.1074/mcp.M110.005330. Epub 2011 Apr 7.

12.

Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response?

Papuć E, Krupski W, Kurys-Denis E, Rejdak K.

J Neural Transm (Vienna). 2016 Apr;123(4):455-61. doi: 10.1007/s00702-015-1477-2. Epub 2015 Nov 14.

14.

Production of autoantibodies to glutamate during Alzheimer's dementia.

Davydova TV, Voskresenskaya NI, Gorbatov VY, Fomina VG, Doronina OA, Maksunova IV.

Bull Exp Biol Med. 2009 Apr;147(4):405-7. English, Russian.

PMID:
19704934
15.

Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.

Giil LM, Kristoffersen EK, Vedeler CA, Aarsland D, Nordrehaug JE, Winblad B, Cedazo-Minguez A, Lund A, Reksten TR.

J Alzheimers Dis. 2015;47(2):523-9. doi: 10.3233/JAD-150053.

PMID:
26401573
16.

Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.

Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC.

J Pineal Res. 2011 Aug;51(1):75-86. doi: 10.1111/j.1600-079X.2011.00864.x. Epub 2011 Mar 1.

PMID:
21355879
17.

Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.

Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M.

Mol Psychiatry. 2008 Oct;13(10):953-69. Epub 2007 Aug 28.

PMID:
17726461
18.

Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.

Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P.

Neurobiol Aging. 2012 Apr;33(4):833.e1-25. doi: 10.1016/j.neurobiolaging.2011.08.001. Epub 2011 Sep 29.

PMID:
21958963
19.

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression.

Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E.

Autoimmun Rev. 2010 Oct;9(12):807-11. doi: 10.1016/j.autrev.2010.07.008. Epub 2010 Jul 23. Review. Erratum in: Autoimmun Rev. 2012 Mar;11(5):374.

PMID:
20656067
20.

Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.

Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa IT, Przybylski M, Manea M, von Arnim CA.

PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.

Supplemental Content

Support Center